Skip Navigation LinksHome > June 2014 - Volume 24 - Issue 5 > Differential Transcriptional and Protein Expression of Thyro...
International Journal of Gynecological Cancer:
doi: 10.1097/IGC.0000000000000139
Basic Science

Differential Transcriptional and Protein Expression of Thyroid-Stimulating Hormone Receptor in Ovarian Carcinomas

Revekka, Gyftaki MD*; Christina, Liacos MD, PhD*; Ekaterini, Politi MD, PhD; Michalis, Liontos MD, PhD*; Katerina, Saltiki MD, PhD; Theocharis, Papageorgiou MD, PhD§; Nikolaos, Thomakos MD, PhD§; Dimitrios, Haidopoulos MD, PhD§; Alexandros, Rodolakis MD, PhD§; Maria, Alevizaki MD, PhD; Aristotelis, Bamias MD, PhD*; Athanasios, Dimopoulos Meletios MD, PhD*

Collapse Box


Objective: Thyroid-stimulating hormone (TSH) regulates normal thyroid function by binding to its receptor (thyroid-stimulating hormone receptor -TSHR) that is expressed at the surface of thyroid cells. Recently, it has been demonstrated that TSHR is abundantly expressed in several tissues apart from the thyroid, among them the normal ovarian surface epithelium. The role of TSHR expression outside the thyroid is not completely understood. The current study examines possible alterations of TSHR expression in ovarian carcinomas and its implication in ovarian carcinogenesis.

Materials and Methods: Quantitative real-time polymerase chain reaction and immunohistochemistry analysis of TSHR expression were performed in 34 ovarian carcinoma specimens and 10 normal ovarian tissues (controls).

Results: Significant reduction in TSHR messenger RNA (mRNA) expression was detected in ovarian carcinomas (mean [SD]: 0.518 [0.0934] vs normal, 49.4985 [89.1626]; P < 0.001, Mann-Whitney U test), whereas TSHR protein levels were significantly increased (percentage of positive cells: cancer, 73.55% [20.09%], vs normal, 54.54% [21.14%]; intensity: cancer, 2.52 [0.508], vs normal 1 [0]; P = 0.012, Mann-Whitney U test). No significant differences in TSHR mRNA were found according to history of thyroid disease.

Conclusions: Our study describes for the first time alterations in TSHR expression both at mRNA and protein levels in ovarian carcinomas. The discrepancy between the decreased levels of the TSHR mRNA and the increased protein expression has already been described in thyroid carcinomas and might be due to alterations in its degradation by the ubiquitin system or other unknown mechanisms. Further analysis could elucidate the role of these findings in ovarian carcinogenesis.

© 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.